Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The most important aim of the ESC Young Thrombosis Researchers Group is to facilitate international networking, thereby strengthening the opportunites for international collaboration. The group is embedded in the ESC Working Group on Thrombosis and creates a strong organisational framework for young researchers interested in thrombosis. Another key aim is to provide member benefits, including grants, mentoring opportunities and international thrombosis meetings.
The "nucleolus" of the ESC Young Thrombosis Researchers Group currently includes the following members:
Mark Thomas, United Kingdom - Chair
Mark graduated from the University of Nottingham, United Kingdom in 2008. He was awarded a prestigious Medical Research Council Clinical Research Training Fellowship in 2012, to investigate the effects of antiplatelet medications on inflammation at the University of Sheffield. His main area of interest is antiplatelet pharmacology, for which he was awarded a Young Investigator Award by the International Society of Thrombosis and Haemostasis in 2011. As a clinician working in translational research, his interests focus on clinical and basic research in thrombosis and coronary artery disease.
Stefan Stojkovic, Austria - Vice-Chair
Stefan graduated at the Medical University of Vienna, Austria, in 2012. After his graduation he enrolled in the PhD program “Vascular Biology”. For his PhD-thesis, under the supervision of Prof. Dr. Johann Wojta, Stefan has received a grant from the Funds of the Austrian National Bank. Main areas of interest are mechanisms of atherosclerotic plaque destabilization and thrombus formation. For his research in this field, Stefan has received several best abstract awards at national and international conferences, as well as the lab exchange grant of the ESC Working group on Thrombosis. Read below his testimony.
Erik Lerkevang Grove, Denmark - Past-Chair & Liaison officer with the WG on Thrombosis
Senior Registrar & Joint Head of Thrombosis Unit, Department of Cardiology, Aarhus University Hospital, Denmark. In 2009 he was a Visiting Research Fellow at the Division of Cardiovascular and Diabetes Research, University of Leeds, UK and in 2011 he defended his PhD thesis on platelet function testing and platelet turnover in coronary artery disease. Other areas of expertise include antithrombotic therapy, acute cardiac care and platelet turnover. He has authored more than 80 papers, clinical guidelines and book chapters.
Mareike Lankeit, Germany - Nucleolus member
Mareike graduated from the University of Göttingen, Germany in 2008, and defended her PhD thesis with summa cum laude in 2010. She has won numerous research awards, fellowships, and research grants e.g. the Best Dissertation Award of the entire University of Göttingen (academic year 2010-2011) and has published more than 25 seminal and frequently cited articles on pulmonary embolism, the pulmonary circulation and right ventricular dysfunction. Since 2012 she has been working as independent researcher and Junior Group Leader at the University of Mainz, Germany. As a clinician and clinical scientist, Mareike is member of the Steering Committee of numerous national and international multicentre trials.
Katharina Hess, Germany - Nucleolus member
Katharina graduated and received his MD from the University of Ulm (Germany) in 2006. After her two-year post-doctoral fellowship at the division of cardiovascular and diabetes research at the University of Leeds (UK) Katharina received a grant from the University of Aachen to develop her clinical and scientific career. Her main areas of interest are in translational research with focus on fibrin clot dynamics in cardiovascular high risk populations. She won several research awards including the Young Investigator Award of the International Society on Thrombosis and Haemostasis 2011 and the Young Investigator Award in Thrombosis of the European Society of Cardiology 2012.
Christoph Varenhorst, Sweden - Nucleolus member
In 2011, Christoph Varenhorst defended his thesis: Platelet Inhibition in Coronary Artery Disease - Mechanisms and Clinical Importance, Studies with Focus on P2Y12-inhibition. Christoph’s scientific work has then continued to focus on platelet inhibition with both clinically oriented but also more basic science oriented papers, all published in high-ranked journals. He now holds a permanent position as a postdoctoral researcher at Uppsala Clinical Research Center (Sweden) and practices as a general and interventional cardiologist at the Uppsala University Hospital.
Area of expertise: Acute coronary syndromes and platelet inhibition
Matthias Freynhofer, Austria - Nucleolus member
Matthias completed Medicine at the Medical University of Vienna (Austria) in 2008 and he is currently finishing his PhD in vascular biology. Therefore he received a grant of the Austrian Society of Cardiology to investigate the influence of platelet characteristics and function on ischaemic and bleeding risks of patients undergoing percutaneous coronary intervention.
As scientist and clinician in training, his areas of interest are mainly atherothrombosis and thromboembolic complications in patients with coronary artery disease and in patients with atrial fibrillation with a focus on risk stratification and individualization of therapy. He is also involved in several multicentre studies, including new medical and device therapies for patients with atrial fibrillation, bradyarrhythmias, coronary heart disease and heart failure.
Marek Postula, Poland - Nucleolus member
Marek graduated from the Medical University of Warsaw, Poland in 2004 and has been working both as a cardiologist at the Department of Cardiology and Hypertension, Central Clinical Hospital, the Ministry of the Interior and clinical pharmacologist at the Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, where in 2008 he defended his thesis in clinical pharmacology. In 2010 he received Fulbright Commission Senior Advanced Research Grant at the Penn State College of Medicine, The Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA. Since then ha has been continuing his research aimed on genetic background of platelet reactivity. He received grants awarded by Polish Science Centre and Polish Ministry of Higher Education. Since 2014 he has been working as an independent researcher holding associate professor position on Medical University of Warsaw. Marek received several research awards including Polish Ministry of Health award in 2015 for his study on pharmacogenomics of platelet reactivity.
Criteria for becoming a member of the Young Thrombosis Researchers Group:
If you would like to apply online and if you are not yet logged in, you will be requested to login via “MY ESC”.Please retrieve your username and password hereIf you do not yet have a My ESC account, please click on "Join Now" to create one.
JOIN NOWThey must fill in the required information and submit a short CV including current role and institution as well as a valid email address of an academic or healthcare institution as evidence.
The chairman will present the applications from suitable new members to the Nucleolus for ratification. Unsuitable applicants (as far as formal requirements are concerned) may be rejected by the Nucleolus. In this case, the applicant will be notified by email but there is no obligation to give him/her reasons.
Different Grants are provided by the ESC Working Group on Thrombosis for members of ESC Young Thrombosis Researchers Group.
This is a Grant to enable attendance to the Eurothrombosis Meetings.
This is a Grant to recognise scientific work presented by young people at the Eurothrombosis Meetings
Visit your Working Group Meeting page to know more about it and submit your abstract.
This is a research Grant to be performed in a Center (clinical or basic) in order to facilitate scientific exchange and collaboration during one year.
Discover more information, read rules and apply
In 2014, 2 young researchers have been selected and received a grant of 25.000 € each for their outstanding projects. Read below their testimonials:
"I am a PhD-Student at the Medical University of Vienna, Austria, in the research group of Prof. Johann Wojta and, with the Lab Exchange Grant from the ESC Working Group on Thrombosis, I will be able to work at the University of Uppsala, Sweden, under the supervision of Prof. Agneta Siegbahn. Agneta Siegbahn is one of the leading scientists in the field of thrombosis and tissue factor signalling. This grant enables the two research groups to collaborate in the field of atherothrombosis and facilitates the exchange of knowledge and experience between them.This project will help to elucidate the impact of the proinflammatory cytokine IL-33 on the coagulation capacity of human whole blood and will give insight into the molecular mechanisms of this process. By investigating tissue factor activity in monocytes subsets and monocyte-derived microparticles, the project aims to further clarify the interplay of inflammation and thrombosis in vascular disease". Dr Stefan Stojkovic
"I am a PhD-student working at Herning Regional Hospital, Denmark, enrolled at Aarhus University and supervised by Associate Professor Steen Husted, one of Europe’s leading experts in thrombocardiology. The grant will allow us to collaborate with the coagulation laboratory at Erasmus Medical Center in Rotterdam, the Netherlands, led by Associate Professor Moniek de Maat, a leading scientist in the field of coagulation analyses and anti-thrombotic therapy. My research stay in Rotterdam is of great importance for my PhD-project and for future scientific cooperation between the institutions involved.Our study focuses on adherence and the role of coagulation assays in patients treated with dabigatran etexilate for non-valvular atrial fibrillation". Dr Willemijn Comuth